PIK3CA and cancer: A highly soluble compound over a wide pH range, Samotolisib (Table 1) is an ATP-competitive inhibitor that effectively inhibits PI3K, mTOR, and DNA-PK, as well as inhibiting the viability of cancer cells and causing cell cycle effects.